• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

Full-dose Blood Thinners Could Prevent COVID-Related Clotting in Hospitalized Patients

by William Jester | Dec 5, 2022 | Community, Covid, News

Anyone who has had COVID-19—even if it was a mild case—is at a higher risk of developing blood clots for months after recovery. If untreated, blood clot complications such as deep vein thrombosis and pulmonary embolism can cause serious damage to the heart or lungs. A...
Researchers discover behavior of immunity genes leading to worse COVID outcomes for men.

Researchers discover behavior of immunity genes leading to worse COVID outcomes for men.

by William Jester | Nov 27, 2022 | Community, Covid, News

Why do men have worse outcomes than women from COVID-19? A new study suggests it’s not something wrong with males, it’s something right with females. Specifically, females’ innate immune systems.A team of researchers from Princeton University, Flatiron Institute of...

The flu hit N.J. early this year. Has COVID made us more vulnerable?

by William Jester | Nov 25, 2022 | Community, Covid, News

Flu season has started earlier than normal in New Jersey, further concerning experts that a bad year could be on the way. Respiratory illnesses are already surging across the state as RSV (respiratory syncytial virus), enterovirus and rhinovirus cases have filled...

Rutgers Recruiting Participants for Pfizer COVID-19 Pediatric Bivalent Vaccine Clinical Trial.

by William Jester | Nov 24, 2022 | Community, Covid, News

Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the safety and efficacy of the bivalent COVID-19 vaccines in children under age 5. Although the U.S. Food and Drug Administration and Centers for Disease...

NJACTS Community Engagement Core COVID-19 Resources

by William Jester | Nov 15, 2022 | Community, Covid, News

The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for...
« Older Entries
Next Entries »

Recent Posts

  • Grant Writing Mini Course – Registration Deadline Today!
  • New Jersey coasts, lined with toxic facilities, don’t fare well in two new studies.
  • Translational Science Competency-Based Assessment Pilot Test Sign Up
  • As few as 2 cigarettes per day linked to 50% increased risk of heart disease: Study
  • What You Need to Know About ‘Ozempic Face,’ According to Doctors.

Archives

  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,404)
  • Covid (993)
  • CTO Events (6)
  • News (3,046)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.